IGF-1 LR3

Long-acting IGF-1 analogue

99.42% HPLC-MSBatch PH-4225 In stock

$115per 1 mg vial

Vial strength

View purity report (COA)Ships in 1 business day

IGF-1 analogue with Arg3 substitution and an N-terminal extension that reduces binding to IGF-binding proteins and prolongs bioactivity. Activates IGF1R and insulin receptor pathways, including PI3K-AKT-mTOR and MAPK.

Specifications

Compound class: Long-acting IGF-1 analogue
Sequence: IGF-1 analogue with Arg at position 3 plus 13-residue N-terminal extension
Chain length: 83 aa
Physical form: Lyophilized powder
Modifications: Reduced IGF-binding-protein affinity
Reported half-life: No reliable therapeutic human PK dataset
Verified purity: 99.42% (HPLC-MS)
Evidence grade: E5 — Preclinical only

Read the full monograph in the Peptide Atlas

Research use only. All products sold on this website are intended for laboratory research and in-vitro experimentation only. They are not drugs, foods, cosmetics, or medical devices, and are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this site should be construed as medical advice, dosing, or administration guidance. Purchasers must be qualified researchers or institutions and are solely responsible for lawful handling and use.